Cytosorbents

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytosorbents and other ETFs, options, and stocks.

About CTSO

CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. 

CEO
Phillip P. Chan
CEOPhillip P. Chan
Employees
221
Employees221
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
2002
Founded2002
Employees
221
Employees221

CTSO Key Statistics

Market cap
60.57M
Market cap60.57M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
161.70K
Average volume161.70K
High today
$1.44
High today$1.44
Low today
$1.33
Low today$1.33
Open price
$1.34
Open price$1.34
Volume
44.18K
Volume44.18K
52 Week high
$8.21
52 Week high$8.21
52 Week low
$1.18
52 Week low$1.18

CTSO Earnings

-$0.25
-$0.17
-$0.08
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 1, After Hours
ActualExpected Nov 1, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.